{
  "pmcid": "6771829",
  "sha256": "38071a98ef2ae834e8908e73f9b5522738495237684917a3090d438c2e466e71",
  "timestamp_utc": "2025-11-09T22:51:53.852253+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.294576719576725,
    "reading_ease": 25.23666666666668,
    "word_count": 216
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Perioperative Chemotherapy with or without Bevacizumab in Gastric and Oesophagogastric Junctional Cancer"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This multicentre, open-label, randomised controlled trial recruited 1063 patients from 2007 to 2014."
      },
      "Participants": {
        "score": 1,
        "evidence": "patients with gastric and oesophagogastric junctional cancer"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive ECX with or without bevacizumab."
      },
      "Objective": {
        "score": 1,
        "evidence": "The primary objective was to assess overall survival."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was overall survival, measured from randomisation to death from any cause."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding was not applied."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "This multicentre, open-label, randomised controlled trial recruited 1063 patients from 2007 to 2014."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Of 1063 randomised patients, 895 underwent resection, with surgical details available for 880."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The trial demonstrated no significant difference in overall survival between the treatment arms."
      },
      "Harms": {
        "score": 1,
        "evidence": "Postoperative complications occurred in 458 patients (52.5%), with 71 (8.1%) experiencing life-threatening complications."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT00450203."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: UK Medical Research Council."
      }
    },
    "total_score": 22,
    "max_score": 25
  }
}